Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Tracking the Evolution of Non–Small-Cell Lung Cancer

1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   МақолаCAR-T cell therapy researchJournal of Hematology & Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000083

2. CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

   Xiao Lyu, Na Zhu, Ruijuan Guo +1

   МақолаCAR-T cell therapy researchCell Biology International20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.012258